Site Nurse Service

Support at Study Centers

Whether at the study center or at the patient’s home: VaLea ct supports you in the practical implementation of your clinical study. We provide trained study nurses and optimize your desired study results with this special manpower.

VaLea’s Site Nurse Service (SNS) reaches the right patient for your study protocol with pinpoint accuracy and ensures the longest possible study participation. We are committed to smooth patient visits and generate high-quality data in optimal time: for your successful study outputs.

If you are interested in a decentralized solution with site nurse service, VaLea ct / Mrs. Valentina Jovanoska will be happy to advise you. The logistical organisation of your clinical trial is of course an integral part of VaLea ct support. We look forward to your study project.


Why Site Nurse Services are important

Are you facing unresolved issues in your study project? Do you want to optimize certain areas? The quality support provided by VaLea ct can contribute to the solution. You can achieve the desired study results by using the study center. Here is an overview of the key benefits for sponsors from VaLea ct’s Site Nurse Service.


  1. Quality improvement of documentation and precise answering of queries
  2. Professional communication with the study team / investigators
  3. Increase in enrolment figures through recruitment management
  4. Personal support without fluctuation in nursing staff
  5. Tailor-made appointments by relieving the clinic personnel

What motivates People to participate in clinical trials?

Top 5 reasons for participating

  1. Progress for future patients
  2. Improve own quality of life
  3. Get the best treatment
  4. Get the latest therapy without high costs
  5. Desire for life-prolonging measures

Around 4,000 people in the USA were asked about their willingness to participate in studies. VaLea ct monitors survey data and practice more closely and adapts the service to current challenges (f.e. COVID-19). The interesting finding from the aforementioned survey is that it strongly depends on the type of study and the level of knowledge of the patients. 65% of the respondents declared their willingness to participate in a clinical trial to cure a disease. 54% would be willing to participate in an observational study. 45% would agree to a new drug or method of therapy as an alternative to standard treatment. (The Patient Perspective on Clinical Trials 2018 / Scorr Marketing, Antidote).

The high level of motivation in the USA cannot be equated for Austria. However, we also read trends for our working environment and adapt the service to the circumstances. The clarification of the safety of the study conduct plus the acceptance of the subjects as responsible, self-deciding partners is of particular importance for the European perspective. VaLea ct provides support in the operational implementation and communication of study projects.


Recruitement & Retention with VaLea Power

In order for trial patients to perceive themselves as responsible, they must be confident about their treatment decisions. These factors also support convinced participation in clinical trials: information about the disease and therapy as well as explanations of the current disease state are essential. Information about the content and procedure of the study is a matter of course.

The professionals at VaLea ct are at your side for the ongoing communication process. This is because study nurses are often the central contact person in clinical trials and answer questions themselves or organise the answering of questions. The partnership with the investigators serves as a mutual support: the expertise of the medical staff reaches the study patients with the help of the study nurses.

Efficient study rounds paired with effective patient contact plus qualitative data is called Site Nurse Service by VaLea ct – for your successful study conduct.


Types of clinical trials

Commercial clinical trials

These are clinical trials ordered by, for example, pharmaceutical or medical device companies. The sponsor takes the initiative and also assumes many responsibilities since the clinical trials are conducted for commercial purposes (e.g. approval of drugs or CE marking of a medical device).

Noncommercial clinical trials

These are academic or investigator-driven clinical trials. Single doctors or academic study groups and institutions, respectively, take the initiative and assume responsibility.

Different approaches exist for both commercial and noncommercial clinical trials:

Interventional vs. observational trials (intervention in the course of the trial vs. no intervention)
Monocenter vs. multicenter trials  (one clinical center vs. several clinical centers)
Controlled vs. uncontrolled trials  (comparison between placebo, standard and zero therapy vs. no comparison)
Randomized vs. non-randomized trials  (assignment by chance vs. assignment based on a system)
Blind vs. double-blind vs. open-label trials  (unawareness of participants vs. unawareness of both participants and researchers vs. awareness of both)
Crossover vs. parallel trials  (both test groups receive both treatments in alternating order vs. each test group always has the same order)
Confirmatory vs. exploratory trials  (argumentation for a hypothesis vs. collecting background information for later argumentation)
Prevalence vs. equivalence trials  (demonstration that the drug is better vs. demonstration that the drug is not worse)